![Digital concept of data flow](https://www.nortonrosefulbright.com/-/media/images/nrf/hero/digital-concept-flow-lights.jpg?w=265&revision=2bcb14f7-5897-4d72-b329-f54ecf1859a8&revision=5250201361707387904&hash=1DBB7BD88F7D40EFEAB403B51B115D8F)
Publication
Generative AI: A global guide to key IP considerations
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Global | Publication | April 2016
Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:
In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.
Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023